Search results
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
1 month ago
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
1 day ago
Author(s):
Ton Duy Mai
,
Tri Huynh Quang Ho
,
Sy Van Hoang
,
et al
Added:
6 days ago
Added:
1 year ago
Source:
Radcliffe Cardiology
AUTHOR: Brad WilsonIn a study published in the Journal of the American College of Cardiology (JACC), Dr Elias Björnson and his colleagues demonstrated that lipoprotein(a) (Lp(a)) is approximately six times more atherogenic than low-density lipoprotein (LDL) per particle.Lp(a) is a lipoprotein particle that has long been recognised as a causal factor for coronary heart disease (CHD). However,…
View more
Author(s):
Harriette Van Spall
,
Rajesh Kharbanda
Added:
1 week ago
ACC 25 - PROTECT-TAVI shows no benefit to routine use of cerebral embolic protection during transcatheter aortic valve implantation (TAVI).Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Rajesh Kharbanda (Oxford University Hospitals NHS Foundation Trust, UK) to discuss the findings from the British Heart Foundation's PROTECT-TAVI Trial, which aimed to determine whether using…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
What should you keep an eye out for at this year's AHA Scientific Sessions?Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) return with their 'View from the Thoraxcenter' preview to highlight late-breaking and featured science trials being presented at this year's AHA Scientific Sessions. Join this dynamic discussion on some of the most anticipated data releases.The…
View more
Author(s):
Harriette Van Spall
,
Roland RJ van Kimmenade
Added:
1 month ago
ACC 25 - FRESH-UP shows liberal fluid intake did not result in a significant difference in health status compared to fluid restriction of 1500ml per day, but did result in a lower perceived thirst distress.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Roland Van Kimmenade (Radboud University Medical Center, Nijmegen, NL) to discuss the findings from the multi-center,…
View more
Alcohol and Heart Failure
Author(s):
Debar Rasoul
,
Ashwin Ajay
,
Alend Abdullah
,
et al
Added:
1 year ago
Article
Author(s):
Dhanunjaya Lakkireddy
Added:
5 months ago
AHA Conference 2024 - Five-Year safety and efficacy follow-up outcomes investigating the non-inferiority of the AMPLATZER Amulet device (Abbott Medical Devices) against the commercially available WATCHMAN (Boston Scientific) device.Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute - HCA Midwest, KS, US) joins us onsite at AHA Conference to discuss the findings from Amulet IDE …
View more
Author(s):
Barbara McGowan
Added:
11 months ago
ECO 2024 — Prof Barbara McGowan (Guy's and St Thomas' Hospital & King's College, UK) joins us to discuss the findings from the STEP 10 trial (NCT05040971, Novo Nordisk).This Phase 3 randomised clinical trial investigated the efficacy and safety of subcutaneous semaglutide 2.4 mg (GLP-1 RA) in 181 participants with obesity (BMI greater than or equal to 30.0 kg/m^2) and prediabetes. The primary…
View more